Point72 Asset Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-40,000
Closed -$3.2M 1925
2024
Q1
$3.2M Buy
+40,000
New +$3.57M 0.01% 1111

Other funds holding CNMD

Point72 Asset Management's CNMD Position: Q1 2026 in Review

Point72 Asset Management increased its CONMED (CNMD) stake by 2.4% in Q1 2026, buying an estimated $128K and bringing the position to 134,114 shares worth $4.74M. The position accounts for 0.01% of the portfolio, ranked #1741.

Point72 Asset Management first reported a position in CNMD in Q2 2014 and has held it in 18 quarters since. The position peaked at $82.3M in Q2 2020. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Point72 Asset Management held 134,114 shares of CONMED worth $4.74M as of Q1 2026.
  • Point72 Asset Management bought 3,156 CONMED shares in Q1 2026, an estimated $128K.
  • CONMED made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1741 holding.
  • Point72 Asset Management first reported a position in CONMED in Q2 2014 and has held it in 18 quarters since.
  • Point72 Asset Management's CONMED position peaked at $82.3M in Q2 2020.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.